5th Circuit Panel Set To Hear Mifepristone Abortion Drug Appeal May 17
NEW ORLEANS — A Fifth Circuit U.S. Court of Appeals panel will hear arguments May 17 in an appeal by the Food and Drug Administration and a drug company challenging district...To view the full article, register now.
Already a subscriber? Click here to view full article